Pipeline Overview

Small molecule discovery and development programmes in the areas of cancer and metabolic diseases.

Our pipeline consists of novel, proprietary and highly-selective targeted therapeutics that are in development to potentially treat a broad array of difficult-to treat indications, including cancer and metabolic diseases. We believe that our pipeline is uniquely positioned to address the limitations of currently available therapies by providing safe and effective treatment solutions.